Top Markets
#1 Islamic Coin Islamic Coin +155.77%
#2 Siren Siren +36.63%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.27%
#4 Arowana Arowana +18.13%
#5 Cysic Cysic +17.36%
#6 aPriori aPriori +15.54%
#7 PulseChain PulseChain +14.70%
#8 Perle Perle +14.18%
#9 The Grays Currency The Grays Currency +13.97%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +13.23%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
NFL Biosciences S.A. NFL Biosciences S.A.

NFL Biosciences S.A.

ALNFL
Rangering i aksjer #31528
Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL... Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.
Aksjekurs
$1.02
Markedsverdi
$12.96M
Endring (1 dag)
-0.92%
Endring (1 år)
-43.11%
Land
FR
Handel NFL Biosciences S.A. (ALNFL)

Kategori

Healthcare
Inntekter for NFL Biosciences S.A. (ALNFL)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til NFL Biosciences S.A. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for NFL Biosciences S.A. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR